Circulation Exam I Drugs

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/75

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 1:09 AM on 9/19/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

76 Terms

1
New cards

Acetazolamide

inhibits CA

causes metabolic acidosis (HCO3- excreted)

Uses: glaucoma, altitude, metabolic alkalosis

2
New cards

Loop diuretics (3)

furosemide, bumetanide, torsemide

3
New cards

loop diuretics MOA and uses

inhibit NKCC2 in TAL

powerful natriuresis

increased urinary Ca2+ and Mg2+

Uses: severe congestion (HF, pulmonary edema)

4
New cards

Thiazide drugs (4)

hydrochlorothiazide

chlorthalidone

indapamide

chlorothiazide (IV)

5
New cards

thiazide drugs MOA and uses

inhibit NCC in early DCT

decreased urinary Ca2+ (more reabsorbed) → NCX

Uses: chronic HTN

6
New cards

potassium-sparing diuretics (4)

spironolactone, eplerenone

amiloride, triamterene

7
New cards

MR antagonists drugs (2)

spironolactone, eplerenone

8
New cards

ENaC blocker drugs (2)

amiloride and triamterene

9
New cards

MR antagonist MOA and uses

decrease ENaC and Na+/K+-APTase gene expression

Na+ not coming in, K+ not going out

  • potassium-sparing

Uses: oppose loop/thiazide K+ secretion

10
New cards

ENaC blocker MOA and uses

block apical Na+ entry

reduced K+ and H+ secretion (potassium-sparing)

Uses: oppose loop/thiazide K+ secretion

11
New cards

mannitol MOA and uses

IV drug, retains water in tubular lumen

Uses: elevated intracranial pressure, not for HTN

12
New cards

ADH agonist drugs (2)

vasopressin and desmopressin

13
New cards

ADH agonist MOA and uses

promotes APQ2 insertion to increase water reabsorption

Uses: water retention and hyponatremia

  • Vasopressin can cause vasoconstriction and HTN


14
New cards

ADH antagonists drugs

tolvaptan and conivaptan

15
New cards

ADH antagonists MOA

V2 antagonists

block ADH binding to prevent APQ2 insertion

  • hold onto water


16
New cards

alpha-2 agonist drugs (2)

clonidine and methyldopa

17
New cards

clonidine uses

resistant HTN → have to taper off

  • rebound sympathetic activation and severe HTN)


18
New cards

methyldopa uses

HTN in pregnancy

19
New cards

hydralazine MOA and uses

vasodilator, causes lots of Na+ and water retention

direct arteriolar relaxation

Uses: difficult to control/resistant HTN

20
New cards

Minoxidil MOA and uses

vasodilator → prodrug → K+ channel opening

  • makes Ca2+ channel less likely to open

very potent

Uses: resistant HTN, hair growth (hypertrichosis)

  • watch out for pericardial effusion

  • start furosemide (VOLUME RETENTION/PULMONARY EDEMA)


21
New cards

labetolol

IV alpha-1 and beta-blocker

lowers resistance without reflex tach

not cardioselective

22
New cards

esmolol

IV beta-1 selective blocker

used for immediate HR control (not BP)

ester, quickly metabolized

23
New cards

ACE inhibitor drugs (common ending)

-pril

  • benazepril, enalapril, lisinopril, etc.


24
New cards

ACE inhibitor MOA

blocks conversion of angiotensin I → II

  • lowers vasoconstriction and aldosterone-mediated Na+ retention

reduces bradykinin breakdown (vasodilation) → excess causes cough/angioedema

25
New cards

Angiotensin II Receptor Blocker (ARB) drugs (ending)

-sartan

  • candesartan, irbesartan, losartan, etc.


26
New cards

ARBs MOA

block angiotensin II receptors

  • reduces vasoconstriction, aldosterone release, sympathetic effects

does not inhibit bradykinin breakdown (less cough than ACE)

27
New cards

ARBs side effects

hyperkalemia (K+ not secreted), kidney effects, and fetal toxicity, angioedema

28
New cards

Aliskiren

directly inhibits renin

not commonly used in HTN

do not combine with ACE inhibitor or ARB

29
New cards

Aliskiren side effects

hyperkalemia, kidney dysfunction, angioedema, fetal toxicity

30
New cards

L-type Ca2+ channel blocker drugs

amlodipine, nifedipine, diltiazem, verapamil


31
New cards

L-Type Ca2+ channel blocker MOA

reduce Ca2+ entry (no contraction) → arteriolar dilation

32
New cards

Dihydropyridine CCB drugs

amlodipine, felodipine, nifedipine, nisoldipine

33
New cards

Dihydropyridine CCB MOA and side effects

arterial dilation with little direct AV-node suppression

ankle edema, flushing, HA, gingival hyperplasia

34
New cards

Nondihydropyridine CCB drugs

ER diltiazem, SR verapamil

35
New cards

Nondihydropyridine CCB MOA and side effects

slow HR and AV conduction → reduce contractility

constipation (verapamil)

36
New cards

Aprocitentan (Tryvio) MOA and uses

antagonist of endothelin receptors

  • reduces vasoconstriction, lowering BP

used for tx of resistant HTN (last line)

37
New cards

beta blockers, cardioselective (3)

metoprolol, atenolol, esmolol

38
New cards

Nonselective beta blockers (2)

propranolol, nadolol

39
New cards

alpha 1 and beta blockers (2)

carvedilol, labetolol

40
New cards

NO-mediated beta blocker (1)

nebivolol

41
New cards

nitroprusside MOA and SE

IV drug

NO donor → arterial and venous dilation

light sensitive, hypotension

42
New cards

Nicardipine/clevidipine MOA and SE

IV drug

DHP CCB → reduce arterial resistance

reflex tach

43
New cards

Fenoldopam MOA and SE

IV drug

D1 agonist → arteriolar dilation

tach, increased intraocular pressure

44
New cards
45
New cards

thiazide-type drug (1)

hydrochlorothiazide

46
New cards

thiazide-like drugs (2)

chlorthalidone and indapamide

increased potency and longer half-life

47
New cards

Which beta blockers are cleared by the kidneys? (2)

atenolol and nadolol

48
New cards

nebivolol

beta-1antagonist

vasodilation via NO release

49
New cards

beta blocker drug interactions

CYP2D6

cimetidine

amiodarone

ritonavir

digoxin

SSRIs

St John’s wort

diltiazem/verapamil

50
New cards

alpha 1 antagonist drugs (2)

doxazosin, prazosin

51
New cards

alpha 1 antagonist MOA and uses

inhibit efferent sympathetic activity

avoids reflex tach

useful with BPH

52
New cards

central alpha 2 agonist drugs (3)

clonidine, methyldopa, guanfacine

53
New cards

central alpha 2 agonist MOA and SE

stimulate central alpha 2 autoreceptors → decrease NE, HR, CO, PVR

withdrawal syndrome→ TAPER

SE: sedation, depression, dry mouth

54
New cards

postganglionic sympathetic inhibitors

deplete NE from nerve terminals → decreased CO and PVR

Reserpine

55
New cards

Stage 1 HTN

(130-139)/(80-89)

56
New cards

Stage 2 HTN

(>140)/(>90)

57
New cards

4 first-line therapies

thiazides

ACE-i OR ARBs

CCB

58
New cards

class for CKD with proteinuria

ACE-i or ARB

59
New cards

class for DM with proteinuria

ACE-i or ARB

60
New cards

class for secondary stroke prevention

ACE-i or ARB

thiazide

61
New cards

AVOID with bronchospastic disease and depression

beta blockers

62
New cards

AVOID with dyslipidemia

beta blockers, diuretics

63
New cards

AVOID with DM

beta blockers, high dose diuretics

64
New cards

AVOID with gout

diuretics

65
New cards

beta blockers okay in HF? (3)

carvedilol, metoprolol suucinate, bisoprolol

66
New cards

CCB okay for HF

amlodipine, felodipine

67
New cards

2 first-line therapies for older adults?

thiazide and CCB

68
New cards

preferred agents in pregnancy (2)

labetalol and nifedipine SR

69
New cards

resistant HTN definition

BP > goal despite 3 BP meds

OR

BP at goal but requires >/= 4 meds

70
New cards

drugs to avoid in bilateral renal stenosis?

ACE/ARB

71
New cards

pre-eclampsia drugs

labetalol

hydralazine

nifedipine

72
New cards

angina/MI drugs

esmolol, nitroglycerin

73
New cards

aortic dissection drugs

esmolol, labetalol

74
New cards

acute pulmonary edema drugs

nitroprusside

nitroglycerin

clevidipine

75
New cards

pre-eclampsia drugs to avoid

ACEI, nitroprusside

76
New cards

acute pulmonary edema drugs to avoid

beta blockers